Abstract
Mucus production is a cardinal feature of bronchial asthma, contributing to morbidity and mortality in the disease. Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway. A number of studies have demonstrated that Th2-type cells play critical roles in this process and that particularly interleukin-13 (IL-13), among Th2-type cytokines, is a central mediator for GCH. However, the mechanism underlying how Th2 cytokines induce mucus production or GCH is poorly understood. Mouse calcium-activated chloride channel-3 (mCLCA-3; gob-5)/human CLCA-1 acts as a downstream molecule of Th2 cytokines, IL-4/IL-9/IL-13 signals, playing an important role in mucus production. Moreover, we have recently found that pendrin, an anion transporter, is induced by IL-13 and causes mucus production in airway epithelial cells. It is hoped that if we can clarify how mucus is produced, this will lead to development of novel therapeutic reagents to suppress mucus production in bronchial asthma.
Keywords: Mucus, bronchial asthma, goblet cell hyperplasia, MUC5AC, Th2 cytokine, pendrin, calciumactivated chloride channel
Current Medicinal Chemistry
Title: The Mechanism of Mucus Production in Bronchial Asthma
Volume: 16 Issue: 22
Author(s): K. Izuhara, S. Ohta, H. Shiraishi, S. Suzuki, K. Taniguchi, S. Toda, T. Tanabe, M. Yasuo, K. Kubo, T. Hoshino and H. Aizawa
Affiliation:
Keywords: Mucus, bronchial asthma, goblet cell hyperplasia, MUC5AC, Th2 cytokine, pendrin, calciumactivated chloride channel
Abstract: Mucus production is a cardinal feature of bronchial asthma, contributing to morbidity and mortality in the disease. Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway. A number of studies have demonstrated that Th2-type cells play critical roles in this process and that particularly interleukin-13 (IL-13), among Th2-type cytokines, is a central mediator for GCH. However, the mechanism underlying how Th2 cytokines induce mucus production or GCH is poorly understood. Mouse calcium-activated chloride channel-3 (mCLCA-3; gob-5)/human CLCA-1 acts as a downstream molecule of Th2 cytokines, IL-4/IL-9/IL-13 signals, playing an important role in mucus production. Moreover, we have recently found that pendrin, an anion transporter, is induced by IL-13 and causes mucus production in airway epithelial cells. It is hoped that if we can clarify how mucus is produced, this will lead to development of novel therapeutic reagents to suppress mucus production in bronchial asthma.
Export Options
About this article
Cite this article as:
Izuhara K., Ohta S., Shiraishi H., Suzuki S., Taniguchi K., Toda S., Tanabe T., Yasuo M., Kubo K., Hoshino T. and Aizawa H., The Mechanism of Mucus Production in Bronchial Asthma, Current Medicinal Chemistry 2009; 16 (22) . https://dx.doi.org/10.2174/092986709788803196
DOI https://dx.doi.org/10.2174/092986709788803196 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Roles of Eosinophils in Cancer Therapy: Epidemiological Studies, Experimental Models, and Clinical Pathology
Recent Patents on Anti-Cancer Drug Discovery Functional Genomics of the Oxidative Stress Pathway
Current Hypertension Reviews Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Cross-Reactive Reactions to Nonsteroidal Anti-Inflammatory Drugs
Current Pharmaceutical Design Potential Applications of FDG-PET/CT in COPD: A Review of the Literature
Current Molecular Imaging (Discontinued) Use of Antihistamines in Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pandemic of Atopic Diseases - A Lack of Microbial Exposure in Early Infancy?
Medicinal Chemistry Reviews - Online (Discontinued) Peptide Sequence Prediction Supported by Correlation-Associated Networks in Human Cerebrospinal Fluid
Combinatorial Chemistry & High Throughput Screening Occupational Exposure and COPD
Current Respiratory Medicine Reviews Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
Current Pharmaceutical Design A Miniaturized Glucocorticoid Receptor Translocation Assay Using Enzymatic Fragment Complementation Evaluated with qHTS
Combinatorial Chemistry & High Throughput Screening Synthesis and Antibacterial Activity of Novel Chalcone Derivatives of Apocynin
Letters in Drug Design & Discovery Statistical Analysis, Optimization, and Prioritization of Virtual Screening Parameters for Zinc Enzymes Including the Anthrax Toxin Lethal Factor
Current Topics in Medicinal Chemistry How to Measure Exercise Performance
Current Respiratory Medicine Reviews Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Heme Oxygenase-1 in Lung Disease
Current Drug Targets Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema – An Overlooked Adverse Drug Reaction?
Current Diabetes Reviews Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Current Respiratory Medicine Reviews Curcumin Therapeutic Modulation of the Wnt Signaling Pathway
Current Pharmaceutical Biotechnology Oxidative Stress-Related Molecules as a Therapeutic Target for Inflammatory and Allergic Diseases
Current Drug Targets - Inflammation & Allergy